China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why biotech in China is booming as well as therapeutic areas where he sees promising science.
The post VC Firm Foresite Capital Dishes on Biotech Innovation in China, Opportunities in Immunology appeared first on MedCity News.
